Truven Emerges from Thomson Reuters Sale

Thomson Reuters has completed the $1.25 billion sale of its healthcare data, analytics and performance benchmarking arm to private equity firm Veritas Capital, which has renamed the business Truven Health Analytics.

The division offers a range of solutions - such as research database MarketScan, healthcare payer decision tool Advantage Suite, clinical reference Micromedex, reporting suite CareDiscovery, and hospital operating trends tool ActionOI - combined with expert analysis.

Under the new name, Truven Health Analytics, the firm employs approximately 2,200 people worldwide, with main offices in Ann Arbor, Chicago and Denver.

CEO Mike Boswood (pictured) - previously CEO of Thomson Reuters Healthcare - comments: 'The healthcare industry is constantly striving for higher quality and improved efficiency, and our new partnership with Veritas Capital will help us harness the power of our world class team to tackle some of the industry's biggest challenges.'

Web site: www.truvenhealth.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.